Cronos Group Inc. (CRON)
USD 1.73
(2.68%)
USD 1.73
(2.68%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -663.32 Million USD | 12.81% |
| 2022 | -760.76 Million USD | 13.27% |
| 2021 | -877.16 Million USD | 17.88% |
| 2020 | -1.06 Billion USD | 10.43% |
| 2019 | -1.19 Billion CAD | -13803.43% |
| 2018 | -8.57 Million CAD | -180.82% |
| 2017 | -3.05 Million CAD | -866.25% |
| 2016 | 398.62 Thousand CAD | 26.39% |
| 2015 | 315.38 Thousand CAD | 153.8% |
| 2014 | -586.22 Thousand CAD | -7943.76% |
| 2013 | -7288.00 CAD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -846.07 Million USD | 0.69% |
| 2024 Q1 | -851.97 Million USD | -28.44% |
| 2023 Q4 | -663.32 Million USD | -16.59% |
| 2023 FY | -663.32 Million USD | 12.81% |
| 2023 Q1 | -410.13 Million USD | 46.09% |
| 2023 Q2 | -406.2 Million USD | 0.96% |
| 2023 Q3 | -568.95 Million USD | -40.07% |
| 2022 Q2 | -780.62 Million USD | 8.41% |
| 2022 Q3 | -626.4 Million USD | 19.76% |
| 2022 Q1 | -852.26 Million USD | 2.84% |
| 2022 FY | -760.76 Million USD | 13.27% |
| 2022 Q4 | -760.76 Million USD | -21.45% |
| 2021 Q1 | -1.01 Billion USD | 4.97% |
| 2021 Q4 | -877.16 Million USD | -5.4% |
| 2021 Q3 | -832.26 Million USD | 6.24% |
| 2021 FY | -877.16 Million USD | 17.88% |
| 2021 Q2 | -887.64 Million USD | 12.56% |
| 2020 Q1 | -1.11 Billion USD | 6.26% |
| 2020 Q2 | -1.09 Billion USD | 1.64% |
| 2020 Q4 | -1.06 Billion USD | 1.82% |
| 2020 FY | -1.06 Billion USD | 10.43% |
| 2020 Q3 | -1.08 Billion USD | 1.05% |
| 2019 Q2 | -1.2 Billion CAD | 33.66% |
| 2019 Q4 | -1.19 Billion CAD | -7.6% |
| 2019 Q3 | -1.1 Billion CAD | 7.65% |
| 2019 FY | -1.19 Billion CAD | -13803.43% |
| 2019 Q1 | -1.8 Billion CAD | -20994.24% |
| 2018 Q1 | -20.73 Million CAD | -578.75% |
| 2018 Q3 | -27.67 Million CAD | 56.69% |
| 2018 Q4 | -8.57 Million CAD | 69.01% |
| 2018 FY | -8.57 Million CAD | -180.82% |
| 2018 Q2 | -63.9 Million CAD | -208.22% |
| 2017 Q3 | -8.58 Million CAD | -153.25% |
| 2017 Q4 | -3.05 Million CAD | 64.4% |
| 2017 FY | -3.05 Million CAD | -866.25% |
| 2017 Q2 | -3.38 Million CAD | 59.68% |
| 2017 Q1 | -8.4 Million CAD | -2208.07% |
| 2016 Q2 | -2.59 Million CAD | -370.31% |
| 2016 FY | 398.62 Thousand CAD | 26.39% |
| 2016 Q1 | 960.63 Thousand CAD | 204.59% |
| 2016 Q4 | 398.62 Thousand CAD | 129.45% |
| 2016 Q3 | -1.35 Million CAD | 47.88% |
| 2015 Q2 | 360.96 Thousand CAD | 82.24% |
| 2015 FY | 315.38 Thousand CAD | 153.8% |
| 2015 Q3 | 927.94 Thousand CAD | 157.08% |
| 2015 Q4 | 315.38 Thousand CAD | -66.01% |
| 2015 Q1 | 198.07 Thousand CAD | 0.0% |
| 2014 Q2 | -208.4 Thousand CAD | 0.0% |
| 2014 Q3 | -661.26 Thousand CAD | -217.3% |
| 2014 FY | -586.22 Thousand CAD | -7943.76% |
| 2013 FY | -7288.00 CAD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Bright Green Corporation | 1.84 Million USD | 36116.622% |
| Alpha Teknova, Inc. | 1.97 Million USD | 33703.18% |
| ANI Pharmaceuticals, Inc. | 94.2 Million USD | 804.116% |
| Aquestive Therapeutics, Inc. | 74.95 Million USD | 985.026% |
| Collegium Pharmaceutical, Inc. | 435.33 Million USD | 252.371% |
| Cosmos Health Inc. | 8.59 Million USD | 7821.401% |
| Journey Medical Corporation | -9.7 Million USD | -6732.081% |
| Embecta Corp. | 1.31 Billion USD | 150.558% |
| Esperion Therapeutics, Inc. | 458.69 Million USD | 244.61% |
| Dynavax Technologies Corporation | 106.63 Million USD | 722.054% |
| Intra-Cellular Therapies, Inc. | -130.82 Million USD | -407.018% |
| Pacira BioSciences, Inc. | 432.74 Million USD | 253.283% |
| PainReform Ltd. | -7.95 Million USD | -8243.733% |
| Sunshine Biopharma, Inc. | -15.63 Million USD | -4142.673% |
| Sunshine Biopharma, Inc. | -15.63 Million USD | -4142.673% |
| SCYNEXIS, Inc. | -19.35 Million USD | -3328.045% |
| Safety Shot Inc | -2.28 Million USD | -28937.56% |
| China SXT Pharmaceuticals, Inc. | -9.42 Million USD | -6934.418% |
| Procaps Group, S.A. | 242.93 Million USD | 373.05% |
| Theratechnologies Inc. | 24.87 Million USD | 2767.069% |
| Harrow Health, Inc. | 116.41 Million USD | 669.785% |
| Sonoma Pharmaceuticals, Inc. | -2.52 Million USD | -26222.491% |
| Biofrontera Inc. | 4.05 Million USD | 16454.21% |
| DURECT Corporation | -7.65 Million USD | -8566.407% |
| Supernus Pharmaceuticals, Inc. | -33.52 Million USD | -1878.485% |
| OptiNose, Inc. | 58.06 Million USD | 1242.387% |
| Ironwood Pharmaceuticals, Inc. | 623.38 Million USD | 206.407% |
| Kala Pharmaceuticals, Inc. | -14.57 Million USD | -4452.064% |
| RedHill Biopharma Ltd. | -5.18 Million USD | -12690.644% |
| Organogenesis Holdings Inc. | 15.01 Million USD | 4518.349% |
| Guardion Health Sciences, Inc. | -6.35 Million USD | -10330.247% |
| Cumberland Pharmaceuticals Inc. | 106.85 Thousand USD | 620849.556% |
| Radius Health, Inc. | 359.28 Million USD | 284.626% |
| Universe Pharmaceuticals INC | 197.2 Thousand USD | 336457.249% |
| ProPhase Labs, Inc. | 19.23 Million USD | 3549.258% |
| Phibro Animal Health Corporation | 454.84 Million USD | 245.835% |
| Procaps Group S.A. | 242.93 Million USD | 373.05% |
| Alvotech | 1.06 Billion USD | 162.324% |
| TherapeuticsMD, Inc. | 3.67 Million USD | 18134.986% |
| Viatris Inc. | 17.13 Billion USD | 103.872% |
| Rockwell Medical, Inc. | 4.45 Million USD | 14986.148% |
| Aytu BioPharma, Inc. | -4.87 Million USD | -13501.123% |
| SIGA Technologies, Inc. | -148.68 Million USD | -346.138% |
| Tilray Brands, Inc. | 158.97 Million USD | 517.247% |
| Lifecore Biomedical, Inc. | 121.89 Million USD | 644.165% |
| Shineco, Inc. | 29.29 Million USD | 2364.663% |
| PetIQ, Inc. | 351.93 Million USD | 288.481% |
| Regencell Bioscience Holdings Limited | -2.9 Million USD | -22762.079% |
| Incannex Healthcare Limited | -5.48 Million USD | -11993.469% |
| Neurocrine Biosciences, Inc. | 177.3 Million USD | 474.127% |
| Alimera Sciences, Inc. | 55.3 Million USD | 1299.311% |
| Silver Spike Investment Corp. | -32.61 Million USD | -1934.019% |
| Assertio Holdings, Inc. | -32.52 Million USD | -1939.186% |
| Shuttle Pharmaceuticals Holdings, Inc. | -1.48 Million USD | -44456.792% |
| Petros Pharmaceuticals, Inc. | -5.06 Million USD | -13008.23% |
| Clever Leaves Holdings Inc. | -4.81 Million USD | -13679.119% |
| Cyclo Therapeutics, Inc. | -8.21 Million USD | -7976.078% |
| Avadel Pharmaceuticals plc | 4.21 Million USD | 15829.826% |
| Hempacco Co., Inc. | 13.61 Million USD | 4972.144% |
| Talphera, Inc. | -5.72 Million USD | -11494.595% |
| Alvotech | 1.06 Billion USD | 162.324% |
| Eagle Pharmaceuticals, Inc. | 7.14 Million USD | 9383.79% |
| Lantheus Holdings, Inc. | -96.71 Million USD | -585.893% |
| Currenc Group, Inc. | -16.57 Million USD | -3902.424% |
| Kamada Ltd. | -46.43 Million USD | -1328.613% |
| Indivior PLC | -33.95 Million USD | -1853.72% |
| Evoke Pharma, Inc. | 260.57 Thousand USD | 254663.682% |
| Flora Growth Corp. | -713 Thousand USD | -92933.207% |
| Cyclo Therapeutics, Inc. | -8.21 Million USD | -7976.078% |
| Evolus, Inc. | 63.7 Million USD | 1141.199% |
| HUTCHMED (China) Limited | -197.45 Million USD | -235.933% |
| Amphastar Pharmaceuticals, Inc. | 479.11 Million USD | 238.449% |
| Akanda Corp. | 3.9 Million USD | 17086.966% |